Admedus has appointed Michael Oswell to the newly created role of vice president, development. Based in the US, Mr Oswell has extensive experience in the medical technology industry. He will be responsible for accelerating Admedus’ product pipeline including its portfolio of 3D surgical solutions and the TAVR project.
Tony Varano, a widely experienced company director, has been appointed non-executive director of OBJ. Mr Varano has more than 30 years of experience across Australia, Europe and USA, operating and managing successful entrepreneurial, corporate and investment pursuits.
Campbell Baird has joined the board of Eastern Goldfields as an independent non-executive director. Mr Baird has been part of the Australian and global mining industry for more than 25 years, with extensive international experience developing projects in Africa, Europe, Asia and South America.
Badri Gosavi has been appointed executive director and chief financial officer of iCollege. Mr Badri is an iCollege top 20 investor and has a history of successful ventures including as owner of restaurants with a turnover exceeding $4.5 million and as part-owner of active mineral exploration ventures in Zambia. iCollege also advises that Stuart Usher will step down as chief financial officer but remains as the company secretary.
Jim Harkins has been appointed technical advisor of Piedmont Lithium. Mr Harkins has over 35 years of experience in mineral processing including 20 years in spodumene concentration. His considerable experience in design engineering, operations, management and quality control of spodumene concentration will provide the company with tremendous knowledge as the Piedmont Lithium Project advances into further technical study. Mr Harkins will participate in all aspects of Piedmont Lithium’s metallurgical testwork program and engineering studies in a peer review capacity.
Roby Zomer, co-founder and chief executive of MGC Pharmaceuticals, has been appointed managing director and will be responsible for execution of the board’s strategy and operations across its Pharma, Botanic and Nutraceuticals divisions. Original managing director and co-founder Nativ Segev will step into the role of executive director and head of business strategy to focus on the company’s group business strategy, to drive sales and secure additional distribution channels for the company division’s products.